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ABCA4ATP Binding Cassette (ABC) transporters play prominent roles in numerous cellular processes and many have
been implicated in human diseases. Unfortunately, detailed mechanistic information on the majority of ABC
transporters has not yet been elucidated. The slow rate of progress of molecular and high resolution structural
studies may be attributed to the difﬁculty in the investigation of integral membrane proteins. These difﬁculties
include the expression of functional, non-aggregated protein in heterologous systems. Furthermore, the extrac-
tion of membrane proteins from source material remains a major bottle-neck in the process since there are rel-
atively few guidelines for selection of an appropriate detergent to achieve optimal extraction. Whilst afﬁnity tag
strategies have simpliﬁed the puriﬁcation of membrane proteins; many challenges remain. For example, the
chromatographic process and associated steps can rapidly lead to functional inactivation, random aggregation,
or evenprecipitation of the target protein. Furthermore, optimisation of high yield and purity, does not guarantee
successful structure determination. Based on this series of potential issues, any investigation into structure–
function of membrane proteins requires a systematic evaluation of preparation quality. In particular, the evalua-
tion should focus on function, homogeneity and mono-dispersity. The present investigation provides a detailed
assessment of the quality of puriﬁed ATP Binding Cassette (ABC) transporters; namely ABCB1 (P-gp) and
ABCA4 (ABCR). A number of suggestions are provided to facilitate the production of functional, homogeneous
and mono-disperse preparations using the insect cell expression system. Finally, the ABCA4 samples have been
used to provide structural insights into this essential photo-receptor cell protein.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
A recent article has labelled ABC transporters akin to a “riddle
wrapped in a mystery inside an enigma” due to their wide range of func-
tions and the complexities surrounding their molecular mechanism [1].
However, this label may equally apply to the difﬁculty in handling ABC
transporters and, for that matter, other polytopic membrane proteins.
Solving this riddle remains an important research goal, as membrane
proteins are the targets for more than 40% of existing pharmacological
agents; a testament to their importance in human health.
Molecular mechanisms of proteins involved in transport processes
have a number of key steps including (i) substrate binding, (ii) binding
site reorientation, (iii) provision of energetics for transport, (iv) cou-
pling substrate binding and energy provision, (v) substrate dissociation,
and (vi) re-setting of the transport machinery [2,3]. Elucidation of ahool of Biology, The Australian
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gleaned from biochemical, pharmacological and structural investigations.
No single discipline can generate sufﬁciently diverse information to pro-
vide a unifying mechanism. The process requires a multi-disciplinary ap-
proach to the problem. Unfortunately, the pace of different disciplines
varies and in the case of ABC transporters, the availability of structural
data remains the “slow runner” in generating molecular mechanisms.
The inherent difﬁculty in attaining high-resolution structural infor-
mation ofmembrane proteins can be illustrated by examining the struc-
tures deposited in the Protein Data Bank (www.rcsb.org). To date, there
are currently 342 high-resolution (i.e. X-ray or NMR based) structures
available for membrane proteins and of these less than 200 are
polytopic. In contrast, in the ﬁrst quarter of 2012 alone, over 2000 struc-
tures of soluble proteins were deposited into the Protein Data Bank.
There are numerous reasons for this lag inmembrane protein structural
resolution, beginning with difﬁculties in their over-expression. The
plasma (or organelle)membrane has aﬁnite capacity for large polytopic
proteins, which limits their heterologous overexpression, compared to
that of soluble proteins. Furthermore the cheap, convenient and high-
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synthesising proteins with molecular weights greater than approxi-
mately 100 kDa. This reduces the choice of expression systems for
eukaryotic membrane proteins, and the typical yields for membrane
proteins are markedly lower than their soluble peers.
To enable chromatographic puriﬁcation, membrane proteins must be
extracted from their native location. This is commonly achieved using
detergents, resulting in the insertion of the protein into a micelle struc-
ture [4]. The amphipathic nature of the detergent should enable both
the structure and solubility of the protein to bemaintained in the solvent
environment. Following puriﬁcation of the protein, crystallisation screen-
ing is undertaken, aimed at inducing ordered aggregation of the protein
species. However, the physical properties of protein–detergent micelles
may hinder the formation of protein–protein contacts that are fundamen-
tal to crystal formation. Due to the differing lateral pressure and relatively
low structural order, detergentmicelles also provide an environment that
allows the membrane proteins to adopt multiple conformations. Since
these proteins, particularly the transporters, are dynamic structures, the
tendency to adoptmultiple conformational statesmay also impair crystal
formation.
Retrospective analysis of membrane proteins that have been
crystallised provides important guidelines for optimal conditions, or
protein quality, required for successful structural determination [5–8].
The yield, concentration and purity of the protein preparations are
established requirements for structural studies. However, ascertaining
the homogeneity, ormonodispersity, should be a primary analytical un-
dertaking for the puriﬁed protein. The homogeneity takes into account
the aggregation state(s) of a protein, the adoption ofmultiple conforma-
tions, and the variety of protein–detergent micelle structures.
Our investigation has characterised the quality of two puriﬁed
human ABC transporters, both of which have considerable importance
in human health. Currently, there are 9 structures for full-length ABC
transporters that have been generated through X-ray crystallography.
Of these, only two are mammalian, one of which is ABCB10 [9] and
the other a mouse isoform of P-glycoprotein (P-gp or ABCB1) [10]. Re-
cently the structure of a Caenorhabditis elegans homologue of ABCB1
has been reported [11]. However, despite attempts from numerous re-
search teams, human ABCB1 has not proven amenable to crystallisation
and the reasons underlying this intransigence remain unclear. ABCB1 is
the archetypal multidrug efﬂux pump and is a key determinant of the
efﬁcacy of chemotherapy in a number of cancer types [12–14]. In addi-
tion, its expression in “normal” (i.e. non-cancer) cells shapes the phar-
macokinetic proﬁle for an extraordinary number of pharmaceutical
compounds. Our laboratories have generated expression, puriﬁcation
and reconstitution systems for ABCB1 during the last two decades and
have invested much effort in optimisation of the protein isolation
[15–21]. In addition, our teams have generated theﬁrst andmost exten-
sive structural data for ABCB1 using electron microscopy and small
angle X-ray scattering based approaches [22–24].
In the present article we outline recent attempts to improve the ho-
mogeneity and stability of puriﬁed human ABCB1 as a ﬁrm foundation
for future structural studies. In addition, the article presents an equiva-
lent optimisation strategy for the ABC transporter associated with
Stargardt disease; namely human ABCA4 protein [25,26]. Considerably
larger than ABCB1 (250 vs 140 kDa), ABCA4 is an interesting compari-
son for the investigations with ABCB1 as it consists of a similar core
functional unit of two transmembrane domains (TMDs) and two nucle-
otide binding domains (NBDs), with the addition of two large soluble
domains on the opposite side of themembrane to the NBDs [27]. More-
over, its putative role in retinal-PE ﬂip–ﬂop in the disc membranes of
photoreceptor cells would render this protein as the only known
human ABC importer.
Our strategy has been to characterise the isolation and stability of
ABCA4 and ABCB1 using a mixture of biophysical and functional ap-
proaches. In addition, the puriﬁed ABCA4 has been used to provide a
low-resolution structure using electron microscopy.2. Materials and methods
2.1. Materials
Trichoplusia ni and Spodoptera frugiperda cells, and foetal bovine
serum (FBS) were purchased from Invitrogen Ltd (Paisley, UK), ExCell
cell culturemedium from SAFC (Dorset, UK) and Insect-XPRESS cell cul-
ture medium, penicillin–streptomycin (P–S) and SeaPlaque agarose
were from Lonza Wokingham Ltd (Berkshire, UK). n-Dodecyl-β-D-
maltoside, n-decyl-β-D-maltoside, n-nonyl-β-D-maltoside, Cymal-5,
the fos-choline detergents (FC-14 and FC-16) and dodecyl-
dimethylamineoxide (all N99% purity) were from Anatrace (Ohio, US);
octyl-β-glucoside and Ni-NTA His-bind Superﬂow resin were from
Merck Biochemicals (Nottinghamshire, UK); complete protease inhibi-
tor tablets were from Roche Diagnostics Ltd (Sussex, UK). Cholesterol
(N99% purity), cholesteryl hemisuccinate tris salt, sodium cholate, soy
bean asolectin, trypsin and DL-dithiothreitol (DTT) were purchased
from Sigma-Aldrich and tris(2-carboxyethyl)phosphine hydrochloride
(TCEP) was from Soltec Ventures (Massachusetts, USA). Columns for
gel permeation chromatography (Superdex 200 10/300 GL, Superose6
10/300 GL, 5 ml Sephadex-G25 PD10 column) and materials for
immobilised metal ion chromatography (5 ml HisTrap columns, Ni-
Sepharose Fast Flow resin) were from GE Healthcare Biosciences
(Buckinghamshire, UK). Millipore (Hertfordshire, UK) supplied 100 kDa
molecularweight cut-off (MWCO) 4 ml and 15 ml centrifugal concentra-
tors, pressure cell concentrators and ultraﬁltration membranes. Low
volume centrifugal concentrators (Vivaspin 500, 100 kDa MWCO) were
from Sartorius Biotechnology Ltd (Surrey, UK). Total Escherichia coli
lipid extract, total porcine brain lipid extract, and porcine brain phospha-
tidyl choline (N99% purity) were purchased from Avanti Polar Lipids
Inc. (Alabama, US). SM-2 adsorbent polystyrene BioBeads and Econo col-
umnswere supplied by Bio-Rad Laboratories (Hertfordshire, UK). Sigma-
Aldrich supplied the following nucleotides and nucleotide analogues:
adenosine 5′-triphosphate disodium salt hydrate, adenosine 5′-
triphosphate magnesium salt (Na2ATP, MgATP), adenosine 5′-
diphosphate disodium salt (ADP), adenosine 5′-(β,γ-imido)triphosphate
tetralithiumsalt hydrate (AMP-PNP), 2′,3′-O-(2,4,6-trinitrophenyl) aden-
osine 5′-triphosphate monolithium trisodium salt (TNP-ATP). Invitrogen
supplied 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin
(CPM). Acrylamide ProtoGel was obtained from National Diagnostics
Ltd (Yorkshire, UK) and PAGE-Blue stain was from Fermentas
(Yorkshire, UK). Precision Plus Protein Kaleidoscope Prestained
standards and the DC-Bio-Rad protein assay kit were from Bio-Rad
Laboratories. Hybond ECL nitrocellulose membrane and the ECL
Western Blotting System (chemiluminescent reagents and photo-
graphic ﬁlm) were supplied by GE Healthcare Biosciences. Skimmed
milk powder was from Waitrose (Berkshire, UK) and Tween-20 was
from Sigma-Aldrich. The monoclonal mouse IgG HRP-conjugated anti-
6xHis antibody was from R&D Systems Europe Ltd (Oxfordshire, UK)
and the monoclonal mouse IgG C219 antibody was purchased from
Merck Biochemicals. [α32P]-8-azido-ATP (575 GBq/mmol) was bought
from Afﬁnity Labelling Technologies (Lexington, USA) and [α32P]-ATP
(29.6 TBq/mmol) was purchased from PerkinElmer LAS (Beaconsﬁeld,
UK). Carbon coated copper EM grids (400 mesh/in.) were from Agar
Scientiﬁc Ltd (Essex, UK) and uranyl acetate was from Sigma-Aldrich.
2.2. Construction of recombinant baculovirus containing ABCA4 or ABCB1
A C-terminal, dodecahexahistidine (His12) tagged isoform of ABCA4
cDNA was generated from an earlier vector (pFastBac1_ABCA4His6)
when initial studies revealed that this hexahistidine tagged isoform
failed to interact strongly with nickel charged afﬁnity resins (data not
shown). pFastBac1_ABCA4His6 contains the cDNA for ABCA4 sub-
cloned in at NcoI and HindIII sites, with an additional, internal NcoI
site present 1.1 kilobase pairs (kbp) from the 3′ end of the cDNA. PCR
primers 5′-GTGAGGAGCACTCTGCAAATCCGTTCCAC and 5′-GCGGTGT
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of an untagged ABCA4 cDNA from pRK5_ABCA4 (kindly supplied by
Dr. J. Nathans (Johns Hopkins University, Baltimore)). The PCR replaced
the stop codon with a BstEII site (underlined), and enabled the sub-
cloning of this product into a vector pBlueBac_ABCB1_His12 at NcoI/
BstEII sites. The latter vector contains the cDNA for human ABCB1
with a BstEII site in frame with a C-terminal His12 tag [18]. The 3′ end
of ABCA4 containing the His12 tag was then sub-cloned back into
pFastBac1_ABCA4His6, generating a plasmid (pFastBac1_ABCA4His12)
which was validated by DNA sequencing and shown to encode a C-
terminal extension of GHHHHHHTGHHHHHH.
The pFastBac1_ABCA4His12 vector was transformed into DH10Bac
cells by heat shock transformation and colonies containing recombinant
bacmid DNA isolated by blue–white screening. Bacmid DNA was pre-
pared by alkaline lysis and was screened by PCR using bacmid primers
(M13F and M13R) in combination with various primers internal to the
ABCA4 cDNA. Recombinant bacmid DNA was transfected into Sf9 cell
monolayers using Cellfectin (3:1 v/w ratio of Cellfectin to DNA) and ini-
tial P1 viruses were harvested 4 days later. The P1 stock was puriﬁed to
remove any parental baculovirus by a plaque assay and blue–white
screen, and the resultant puriﬁed recombinant virus was ampliﬁed
and titred as previously described [28].
AC-terminal, dodeca-histidine taggedABCB1 isoformwas constructed
as previously described. The poly-histidine tag was engineered into the
cDNA of ABCB1 to contain a human rhinovirus 3C-protease cleavage site.
2.3. Tissue culture and membrane preparation
Sf900 insect cells were routinely grown at 27 °C in Insect-XPRESS
medium supplemented with 100 U/ml penicillin and 0.1 mg/ml strep-
tomycin. Cell suspensions (5 × 106 cells/ml)were infectedwith recom-
binant baculovirus containingABCA4 at amultiplicity of infection (MOI)
of 5.
ABCB1 was expressed in T. ni (Hi5) insect cells as previously
described [18]. Brieﬂy, Hi5 cells at a density of 3 × 106 cell/ml were
infected with baculovirus containing ABCB1 at a MOI of 5.
Cells (Sf900 or Hi5) were diluted 1:1 and grown for 3–4 days with
shaking at 140 rpm at 27 °C. Infected cells were collected by centrifuga-
tion and stored as pellets at −80 °C until membrane preparation.
Crude membranes were prepared by nitrogen cavitation and ultra-
centrifugation as previously described [19]. The ﬁnal membrane prepa-
rations were ﬂash frozen in liquid nitrogen and stored at a protein
concentration of 20–50 mg/ml at−80 °C for up to 12 months.
2.4. Solubilisation procedures for ABCA4 and ABCB1
All solubilisation screens were carried out in a standard solu-
bilisation buffer of 20 mMMOPS pH 7.4, 200 mMNaCl, 20% (w/v) glyc-
erol, 1.5 mMMgCl2 and 5 mMDTT. This buffer was supplemented with
2% (w/v) detergent and membranes added to a ﬁnal protein concentra-
tion of 5 or 10 mg/ml. This mixture was brieﬂy homogenised and incu-
bated at 4 °C for 60 min with stirring. Following incubation with
detergent, insoluble material was removed by ultracentrifugation and
the supernatant, containing solubilised proteins, retained for chroma-
tography. The insoluble fraction was re-suspended in 10% (w/v) SDS
and diluted to the same volume as the soluble fraction. The efﬁciency
of the solubilisation procedure was monitored by assessing the
partitioning of the protein of interest between the soluble and insoluble
fractions using a Western blot.
ABCA4 was solubilised for routine chromatography using the stan-
dard solubilisation buffer supplemented with 2% (w/v) FC-16. The
concentration of total membrane proteins in the solubilisation mixture
was 5 mg/ml. In puriﬁcations that included lipids the lipid mixtures
were dissolved in a solvent of 2:1 chloroform:methanol (v/v). Lipid
ﬁlms were prepared from this solution by evaporating the mixture
under vacuum for at least 60 min. The lipid ﬁlms were re-suspendedin solubilisation buffer containing detergent by repeated sonication
and vortexing until the lipids were evenly dispersed.
For the routine solubilisation of ABCB1, total E. coli lipid extract and
cholesterolweremixed in a ratio of 4:1 (w/w) and dissolved in a solvent
of 2:1 chloroform:methanol (v/v). Lipid ﬁlms were prepared from this
solution by vacuum evaporation and the ﬁlms re-suspended in
solubilisation buffer containing 2% (w/v) dodecyl-β-maltoside to a
ﬁnal lipid concentration of 0.4% (w/v). Isolated insect cell membranes
were added to the detergent–lipid mixture at 5 mg/ml protein. This
mixture was stirred at 4 °C for 120 min and solubilised proteins were
recovered by ultracentrifugation.
2.5. Puriﬁcation of ABCA4
ABCA4 membranes containing N500 mg total membrane pro-
teins were puriﬁed using a pre-packed 5 ml HisTrap column equili-
brated using puriﬁcation buffer (20 mM MOPS pH 7.4, 200 mM
NaCl, 10% (v/v) glycerol) supplemented with 5 mM TCEP, 0.01% FC-16
and lipidswere required. Solubilised ABCA4was loaded onto the column
at a ﬂow-rate of 0.5 ml/min. The ﬂow rate was increased to 1.5 ml/min
and a step-wise gradient of 40–400 mM imidazole was introduced
to wash and elute the protein. At this point, the puriﬁcation buffer
containing FC-16 could be exchanged for a buffer including 0.05% β-
dodecylmaltoside (β-DDM). Protein was concentrated by ultra-
ﬁltration (100 kDa cut-off, Millipore, UK) to b250 μl. Gel permeation
chromatography (GPC) using a Superose 6 10/300 column (Retention
volume (Ferritin 440 kDa = 14.8 ml)) was used as the second puriﬁca-
tion step. Proteinwas loaded into a 500 μl sample injection loop, injected
onto the column and eluted at a ﬂow rate of 0.5 ml/min. Fractions were
automatically collected in 0.5 ml aliquots.
2.6. Puriﬁcation of ABCB1
Supernatants of solubilised ABCB1 were fractionated using a 5 ml
HisTrap columnwith a stepwise gradient from40 to 800 mM imidazole.
Solubilised material was passed through the column at 1 ml/min. The
ﬂow-rate was then increased to 3 ml/min for washing and elution
phases. Selected fractions were concentrated using centrifugal ultra-
ﬁltration concentrators (Millipore, UK, 100 kDa cut-off). GPC was
performed in 20 mMMOPS pH 7.4, 200 mMNaCl, 5 mMTCEP, 5% glyc-
erol, 0.02% DDM on a Superdex S200 10/300 column (Void volume =
8.5 ml; Conalbumin (75 kDa) = 15.4 ml) at a ﬂow rate of 0.3 ml/min.
2.7. Buffer exchange
Fractions from metal afﬁnity puriﬁcations were eluted in buffer
containing 400 mM imidazole. This was removed via buffer exchange
into an imidazole-free buffer using a 5 ml Sephadex-G25 PD10 column.
The column was equilibrated in standard puriﬁcation buffer used for
ABCA4 or ABCB1 containing the respective detergent but no imidazole.
Columns were loaded with protein sample, which typically eluted from
the PD10 column between 2 and 4 ml. Fractions containing protein
were identiﬁed by SDS-PAGE and pooled.
2.8. Thermal stability assay
The thermal stability assay was carried out in a 96-well plate format
as previously described [29,30]. Puriﬁed protein at 5 mg/mlwas diluted
into detergent-free puriﬁcation buffer (20 mM MOPS pH 7.4, 200 mM
NaCl, 10% (v/v) glycerol, 5 mM DTT). Additives to this buffer, or alter-
ations from its standard composition, are detailed in the ﬁgure legends
and text. The ﬂuorescent probe CPMwas added to a ﬁnal concentration
of 0.7 μg/ml and the samples incubated at 37 °C in a ﬂuorescent plate
reader. Fluorescence was measured every 5 s for 120 min using
λex = 390 nm and λem = 450 nm. Fluorescence intensity was plotted
directly as a function of time, or converted to stability units using the
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rescence reading at each time point and Fmax was the maximum ﬂuores-
cence for the data set. The rate-constant (k) of the folded protein in each
condition was calculated by ﬁtting the data with a single exponential
decay curve: Y = S ∗ e−kt + P, where Y = stability unit, t = incubation
time, S = span of stability units, P = plateau and k = rate constant. The
half-life (t1/2) was calculated from the rate constant thus: t1/2 = 0.69 / k.
2.9. ATPase assay — colorimetric method
The ATP hydrolytic activity of ABCB1 was determined by measuring
the liberation of inorganic phosphate using a modiﬁed [20,28] colori-
metric assay [31]. The maximal ATPase activity was measured using
0.5–1 μg puriﬁed protein and 2 mM Na2ATP in ATPase buffer (50 mM
Tris·HCl pH 7.4, 150 mM NH4Cl, 5 mM MgSO4, 0.02% (w/v) NaN3).
Stimulated activity wasmeasured in the presence of 10 μMnicardipine.
Samples were incubated in the dark at 37 °C for 20 min and the inor-
ganic phosphate measured as described.
2.10. ATPase assay — radioactive method
ATP hydrolysis was measured for puriﬁed ABCA4 by following the
formation of [α32P]-ADP from [α32P]-ATPwith thin layer chromatogra-
phy (TLC). Michaelis–Menten parameters of hydrolysis were obtained
by incubating ABCA4 (1 μg) with 0–5 mM ATP and a trace amount
(74 kBq) of [α32P]-ATP in a 1:1 mixture of puriﬁcation and ATPase
buffers. The total sample volume was 50 μl and samples incubated for
60 min at 37 °C. At 10 min intervals, a 1 μl aliquot was spotted onto a
cellulose-PEI TLC plate. TLC was done using 0.5 M LiCl, 1 M formic
acid at 20 °C; plates were then dried and exposed to Kodak BioMax
MS ﬁlm. The latter was used to identify bands corresponding to ATP
and ADP. The latter were cut out of the plates and radioactivity deter-
mined using a scintillation counter. The amount of ADP formed (nmol/
mgprotein)was plotted as a function of time and the slope of this linear
relationship was used to provide the rate of ATP hydrolysis. The rate of
hydrolysis was calculated at a number of ATP concentrations and the
data used to determine the characteristic parameters ofmaximal hydro-
lytic rate (VMAX) and afﬁnity (KM) for nucleotide.
The effects of retinal derivatives, or nucleotide trapping strategies,
on ATP hydrolysis were investigated by incubating protein with a
ﬁxed concentration of nucleotide (2 mM ATP and 74 kBq [α32P]-ATP).
Additives were dispensed from concentrated stocks to ensure minimal
proportion of solvent (b1%). Retinal derivatives were kept as stocks in
dimethyl-sulfoxide (DMSO) whilst nucleotides (AMP-PNP) were from
100 mMMOPS pH 7.4 buffer.
2.11. Electron microscopy
Grids were glow-discharged to increase the afﬁnity of the carbon
support for the protein sample as previously described [32]. Protein
was adsorbed onto the grid and stainedwith uranyl acetate as previous-
ly described [33]. Brieﬂy, grids were placed on a 5 μl drop of protein
sample. After removal from the protein droplet, the grid was blotted
with Whatman paper to remove excess liquid and washed with H2O.
After blotting to remove excess water, the grid was placed on a 5 μl
drop of 4% (w/v) uranyl acetate to overlay the protein layer on the
grid with a layer of stain. Excess stain was removed by blotting with
Whatmanpaper.Micrographswere recorded using a JEOL 100 kV trans-
mission electron microscope connected to a 3 k × 2 k Gatan CCD cam-
era (University of Manchester) at a magniﬁcation of 150,000. Particles
were automatically boxed and classiﬁed using the EMAN processing
suite as previously described [33,34].
Twenty-ﬁve well deﬁned and different projection averages from
these classes were used to generate an unsymmetrised 3-D volume
whichwas reﬁned and produced a 3-D structurewith a clear C2 dimeric
appearance (data not shown). This structure was re-reﬁned with C2symmetry, to reconstruct a 3D volume of the complex at a ﬁnal resolu-
tion of 26 Å. Back projections from this 3Dmodel had a clear correspon-
dence with the class averages and raw particle images, and did not
exhibit any initial model dependence.
2.12. Data analysis
All investigations were undertaken with a minimum of three inde-
pendent protein puriﬁcations and date representmean ± SEM. Statisti-
cal analyses were done using GraphPad Prism 4.0 and a P-value b 0.05
was considered signiﬁcant. Linear and non-linear regression analyses
were also performed using this program.
3. Results
3.1. Expression and solubilisation of ABCA4
In contrast to ABCG2 and ABCB1, which demonstrate high level
expression of full-length protein in High 5 insect cells [19,35], ABCA4
was reproducibly truncated to 160 kDa in this cell line. There was no
such problem in Sf900 cells (Sf9 cells grown in the absence of serum)
with high expression in crude membranes at the expected molecular
weight of 250 kDa. The membrane yield from a 1 litre culture of Sf900
cells was 156 ± 16 mg protein.
A range of conventional detergents, that have demonstrated wide
applicability to membrane proteins, were chosen to extract ABCA4
from crude Sf900membranes (Fig. 1a). This strategy involved collection
of detergent soluble protein in supernatants following 60 min extrac-
tion in surfactant concentrations in excess of their CMC. As shown in
Fig. 1a, none of the detergents tested were able to effect extraction of
ABCA4. The data in Fig. 1a was achieved using a total protein concentra-
tion of 10 mg/ml but similar observations were made at 1 mg/ml,
which would be expected to facilitate extraction due to the higher
detergent:membrane ratio. Similarly, using elevated temperatures
(37 °C) or longer incubation periods (up to 24 h) also failed to facilitate
the extraction of ABCA4 (data not shown). SDS was utilised in the
screens and this strong ionic detergent readily extracted ABCA4 from
the Sf900 membranes. A large range of stronger non-ionic and zwitter-
ionic detergent species were subsequently examined (Fig. 1b). The
phosphocholine (FC) detergents proved considerably more adept at
extracting ABCA4 from Sf900 membranes. The short chain FC-8 species
extracted approximately 20% of ABCA4 (data not shown) and the
solubilised fraction of the protein was increased to greater than 60–
70% with the longer chain length of FC-14 and FC-16. Similar results
were obtained using a low initial membrane concentration although a
small proportion of the ABCA4 always remained in the detergent insol-
uble pellet.
Fig. 1c shows that the presence of the reducing agent DTT played a
major role in the determining the efﬁciency of ABCA4 extraction. Even
at a FC-14 concentration of 2% (w/v) there was no extraction of
ABCA4 in the absence of 2.5 mMDTT (Fig. 1c). In contrast, the presence
of reducing agent supported efﬁcient extraction of ABCA4. The data
obtained in Fig. 1a–bwas obtained in the presence of DTT and all subse-
quent investigations were under reducing conditions. The biophysical
properties of FC detergents are not well described and the use of
mixed micelles in the presence of the more conventional (e.g. DDM)
detergent was explored. As expected, ABCA4 was extracted in the pres-
ence of 2% (w/v) FC-14 (Fig. 1d). Rather surprisingly, the inclusion of 1%
(w/v) DDM abrogated the extraction of ABCA4 and even increasing the
surfactant concentration to 2% (w/v) failed to improve solubilisation.
The underlying reason for this unwanted interaction between the deter-
gents was unexplained and similar results were obtained with the
substitution of OG for DDM, or the substitution of FC-16 for FC-14
(data not shown).
Thus, ABCA4, like several ABC transporters, is difﬁcult to extract from
insect cellmembranes and theoptimal conditions to effect solubilisation
Fig. 1. Solubilisation of ABCA4 from Sf9 insect cell membranes. Insect cell membranes
(10 mg/ml) were incubated in the presence of 2% (w/v) of a range of detergent species
for 60 min. Solubilised proteins were harvested by ultra-centrifugation at 100,000 ×g
for 30 min. Pellets were solubilised in the presence of 2% (w/v) SDS and fractions of
both were examined by SDS-PAGE and immuno-blotting. a) Detergent species used
were dodecyl-β-maltoside (DDM), CHAPS, octyl-glucoside (OG) and perﬂuoro-octanoic
acid (PFO). Arrows refer to supernatant fractions following ultra-centrifugation, whereas
unmarked lanes contain proteins in the pellet. b) Detergent species used were digoxin
(DIG), fos-choline 14 (FC-14), fos-choline 16 (FC-16), cyclofos 5 (CF-5), cyclofos 7 (CF-
7) and sodium dodecyl-sulphate (SDS) as a positive control. Arrows refer to supernatant
fractions following ultra-centrifugation, whereas unmarked lanes contain proteins in the
pellet. c) Membranes were treated with FC-14 in the presence or absence of 2.5 mM
DTT. Lane assignments are: M — membranes, P — pellet following ultra-centrifugation
and S — supernatant following ultra-centrifugation. d) Membranes were treated with FC-
14 in the absence or presence of DDM (1–2%w/v). Lane assignments are: M—membranes,
P — pellet following ultra-centrifugation and S — supernatant following ultra-
centrifugation.
Fig. 2. Chromatographic puriﬁcation of ABCA4 and ABCB1. Solubilised proteins were
separated using IMAC and GPC. Columns were washed in increasing concentrations of
imidazole and fractions collected at each stage. a) Metal afﬁnity puriﬁcation of ABCA4.
The Ni-NTA resinwaswashed in 0–100 mM imidazole and ABCA4was eluted in the pres-
ence of 250 mM imidazole. b) Metal afﬁnity puriﬁcation of ABCB1. The Ni-NTA resin was
washed in 10–100 mM imidazole and ABCB1 was eluted in the presence of 400 mM im-
idazole. Representative fractions from the ﬂow-through (FT), wash and elution stages of
Ni-NTA chromatography were analysed by SDS-PAGE with protein detection using
PageBlue reagent. Fractions containing ABCA4 or ABCB1 were pooled and concentrated.
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of 10 mg/ml for 60 min at 4 °C, under reducing conditions. These initial
solubilisation conditions were utilised in all subsequent puriﬁcation
procedures with ABCA4.
3.2. Puriﬁcation of ABCA4 using metal afﬁnity chromatography
ABCA4 had been engineered with a dodeca-histidine tag to enable
chromatographic separation using metal afﬁnity chromatography with
Ni-NTA resin. Initial studies with a hexa-histidine tag failed to generate
protein of sufﬁcient purity (b60%) and were discontinued in favour of
the dodeca-histidine isoform. The FC-16 solubilised Sf900 membranes
were applied to the Ni-NTA resin at a reduced ﬂow rate to maximisebinding of poly-histidine containing proteins. As shown in Fig. 2a
there was no ABCA4 in the initial ﬂow through fractions, as detected
by PageBlue staining. The initial washing stages of chromatography
progressed from 0 to 80 mM imidazole and in order to elute the high
afﬁnity binding of ABCA4, the imidazole concentration was raised to
250 mM. ABCA4 eluted at 250 mM imidazole with a purity of approxi-
mately 80–85%.
3.3. Puriﬁcation of ABCB1 using metal afﬁnity chromatography
Since many isoforms of ABCB1 expressed in insect cells were known
to solubilise well in DDM, extensive screening of detergents was not
carried out for ABCB1. However, we did observe an apparent inverse
relationship between the duration of the expression and the detergent
“extractability” of ABCB1, with 48–60 hour incubation post-infection
being a suitable compromise. Fig. 2b demonstrates the progression of
ABCB1 (containing a protease cleavage site for the C-terminal dodeca-
histidine tag) puriﬁcation using an automated chromatography system,
which has not previously been shown from our laboratory. The ABCB1
was eluted by an imidazole concentration of 400 mM and the purity
following chromatography with the HisTrap resin was approximately
70–75% (estimated by densitometric analysis). The gel in panel b
was over-exposed to reveal minor contaminants; with the most com-
mon bands at approximately 50 kDa and 80 kDa detected by C219,
the monoclonal antibody to ABCB1 (data not shown). These minor
contaminating bands were not observed following gel permeation
chromatography.
3.4. Analysis of ABCB1 and ABCA4 homogeneity by gel permeation
chromatography
Themetal afﬁnity chromatography steps described above generated
ABCB1/ABCA4 preparations that had purity of approximately 80%. Mod-
ifying the metal afﬁnity chromatography conditions did not achieve suf-
ﬁcient improvement in purity. Consequently, an additional puriﬁcation
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advantage of GPC is the ability to exchange buffer composition to
one more compatible with structural or functional investigation;
in particular, the removal of the high concentration of imidazole
(400 mM). GPC also provides a convenientmeasure of the homogeneity
or mono-dispersity of the puriﬁed protein preparations and enables the
removal of aggregated species. Prior to GPC, the transporters were con-
centrated using centrifugal concentrators as described in the Materials
and methods section.
ABCA4 (MW ~ 250 kDa) was subjected to GPC using a Superose 6
column,which has an optimal separation range for soluble globular pro-
teins of 5–5000 kDa. A typical GPC proﬁle (i.e. UV absorbance at
280 nm) for ABCA4 is shown in Fig. 3a (solid line) and samples corre-
sponding to elution volumes of 6–12 ml were analysed by SDS-PAGE
(Fig. 3c). The GPC proﬁle revealed two major peaks; one at RV = 8 ml
and another broader peak between RV = 9–12 ml. The SDS-PAGE anal-
ysis indicated that ABCA4 was observed in every fraction from 7 ml
to 12 ml and ran at its predicted monomeric molecular weight of
~250 kDa. However, fractions at RV = 7–9 ml also contained protein
at higher molecular weight that barely penetrated the 6% acrylamide
gel. Immuno-blotting of the gels indicated that these higher molecular
weight bands also contained ABCA4. Any ABCA4 eluting at RV = 7–
9 ml, which corresponds to the column void volume, is likely to be irre-
versibly aggregated protein. The strength of the aggregation was
conﬁrmed by the lack of disruption by SDS and reducing agents in the
electrophoresis step. In summary, the combination of GPC and electro-
phoresis revealed that the ABCA4 preparations contained signiﬁcant
heterogeneity.
GPC of IMAC-puriﬁedABCB1 (MW ~ 140 kDa)was performedwith a
Superdex 200 column,whichhas a resolving range of 3–600 kDa. Fig. 3b
(solid line) shows theGPC proﬁle for ABCB1with the SDS-PAGE analysis
of fractions corresponding to RV = 6–12 ml (Fig. 3d). The GPC proﬁle
for ABCB1 also contained two poorly resolved peaks (RV 8 ml andFig. 3. Effects of imidazole on the homogeneity of ABCB1 and ABCA4. Typical GPC traces are show
lines) of imidazole. The imidazole was used in eluting protein fromNi-NTA resin and removed,
using the chromatography systemﬂow cell. Spectral intensities for each tracewere normalisedw
were resolved on Superose 6 and Superdex 200 columns respectively. (c) Concentrated, puriﬁe
resentative fractions are shown for the void and included fractions. (d) Concentrated, puriﬁed A
resentative fractions are shown for the void and included fractions.11.5 ml respectively), and the protein was observed in all fractions.
The earlier peak at RV = 8 ml contains higher molecular weight forms
of ABCB1, which are most likely aggregated protein. The lack of com-
plete resolution between the two ABCB1 containing peaks meant that
the ﬁnal samples were not mono-disperse and contained signiﬁcant
heterogeneity.
3.5. Do buffer components affect the homogeneity of ABCA4 and ABCB1?
The involvement of buffer components in maintaining homogeneity
and mono-dispersity of puriﬁed proteins is widely recognised. Conse-
quently, preparation of puriﬁed proteins and their subsequent crys-
tallisation requires considerable screening of buffer components for
their effects on protein state. Of the components used in our buffers for
membrane protein puriﬁcation the imidazole present in the elution frac-
tions was not a requirement thereafter. Consequently we sought to as-
certain the effect of the high imidazole concentration on protein state
by using buffer exchange (PD-10 column) immediately following
metal afﬁnity chromatography prior to concentrating the protein sample
for GPC. The resultant GPC proﬁles for ABCA4 concentrated with and
without imidazole are shown in Fig. 3a. The removal of imidazole (dot-
ted line) considerably improved the GPC proﬁle characterised by a
major peak at RV =10.7 ml. This fraction of ABCA4 overlaps directly
with the peak obtained in the presence of imidazole. A small “shoulder”
peak remained in the region of the void volume and although this peak
contained aggregated ABCA4, it accounted for only a minor fraction of
the sample.
The comparative GPC proﬁles for ABCB1 obtained in the presence or
absence of imidazole at the concentration step are shown in Fig. 3b.
Both spectra contained a major peak eluting at RV = 11.5 ml, which is
believed to correspond to mono-disperse ABCB1. The proportion of
ABCB1 found in the peak fraction of the void volume (i.e. RV = 8 ml)
was considerably reduced by removal of imidazole in the buffer.n for (a) ABCA4 and (b) ABCB1 obtained in the absence (dashed lines) and presence (solid
where necessary, using PD-10 columns. Proteins were identiﬁed by absorbance at 280 nm
ith the assignment of themain peak intensity for ABCA4/ABCB1 to 100. ABCA4 and ABCB1
d ABCA4 was subjected to gel permeation chromatography on a Superose 6 column. Rep-
BCB1 was subjected to gel permeation chromatography on a Superdex 200 column. Rep-
Fig. 4. Effects of storage conditions on protein homogeneity. a) Puriﬁed ABCA4 samples
were passed through PD-10 columns to remove imidazole. A fraction of the sample was
subjected to GPC chromatography (Superose 6) immediately and the resultant proﬁle
shown in solid line. Another aliquot of the protein was stored at 4 °C for 7 days, subjected
to GPC and the proﬁle shown with a dotted line. b) Puriﬁed ABCB1 samples were passed
through PD-10 columns to remove imidazole. A fraction of the sample was subjected to
GPC chromatography (Superdex 200) immediately and the resultant proﬁle shown in
solid line. Another aliquot of the protein was stored at 4 °C for 7 days, subjected to GPC
and the proﬁle shown with a dotted line. A further aliquot was ﬂash frozen and stored
at−80 °C for 7 days, subjected to GPC and the proﬁle shown with a dashed line.
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in dictating the state of puriﬁed proteins and supports screening to en-
sure quality of preparations. In the case of ABCA4 and ABCB1, high con-
centrations of imidazole should be removed immediately following
metal afﬁnity chromatography to prevent aggregation of puriﬁed pro-
tein. Finally, the use of GPC also improved the purity of the ﬁnal prepa-
rations for both proteins and the combined strategy is a powerful
mechanism to achieve mono-dispersity.
3.6. Does storage of ABCB1 and ABCA4 adversely affect the sample
homogeneity?
Puriﬁcation of membrane proteins for long-term structural projects
inevitably requires storage of puriﬁed protein. Indeed, structural studies
involve extended incubation to promote crystal growth. Consequently,
the effects of prolonged storage of ABCA4 and ABCB1 were investigated
using GPC as a measure of the sample homogeneity. Both proteins were
puriﬁed using the combination of metal afﬁnity chromatography and
GPC as described in the previous sections, with imidazole removed
following metal afﬁnity chromatography.
Puriﬁed ABCA4 was stored at 4 °C in the dark for a period of 7 days
and a sample analysed by GPC. The chromatographic proﬁle for protein
prior to, and following, storage at 4 °C is shown in Fig. 4a. The ABCA4
peak was near symmetrical with a RV = 11 ml and there was no alter-
ation in peak symmetry or retention volume following prolonged stor-
age at 4 °C. In addition, there was no alteration in the amount of
protein found within the void volume, which indicates minimal aggre-
gation in the buffer system employed for the storage. There was an
increase in the peak at RV = 20 ml, however this did not correspond
to any protein-based material.
Puriﬁed ABCB1 was also subjected to the same storage conditions
and the effects on the GPC proﬁle are shown in Fig. 4b. The GPC proﬁle
for protein stored for 7 days at 4 °Cwas similar to that of protein imme-
diately after metal afﬁnity chromatography. The GPC proﬁle offered
little evidence of aggregation in the sample; the size, shape and reten-
tion volume of the principal peak were largely unchanged between
the two conditions. Therewas a small increase in the amount ofmaterial
eluting at higher retention volumes (~17.5 ml). These peaks correspond
to lower molecular weight species and are thus likely to be proteolytic
fragments of ABCB1 that were liberated following storage for
7 days at 4 °C. ABCB1 was also ﬂash frozen in liquid nitrogen and
stored at −80 °C for 7 days. The GPC proﬁle revealed that the sample
had less evidence of low molecular weight species at RV = 17.5 ml.
However, there was a noticeable increase in the amount of protein elut-
ing in the void volume (Fig. 4b), which is indicative of aggregation pro-
pensity. These data indicated that protein storage is an important
consideration as a freeze–thaw cycle for ABCB1 appeared to induce
aggregation, whereas storage at 4 °C resulted in minor degradation.
3.7. The use of an isothermal stability assay to assess protein stability
Detergent extraction of membrane proteinsmay have severe conse-
quences for protein activity and overall stability, particularly if the pro-
cess removes annular lipids. The inclusion of “stabilising agents” such as
lipids and osmo-protectants may afford increased stability to the isolat-
ed proteins. Based on this information, screening additives to improve
protein integrity is a hallmark feature of most structural initiatives.
The thermal stability assay provides a rapid and high capacity sys-
tem to screen stabilising additives. In the present investigation an iso-
thermal version of the assay was adopted. Puriﬁed ABCB1 and ABCA4
were incubated in the presence or absence of stabilising compounds
at an elevated temperature. The latter induces gradual protein unfolding
(i.e. denaturation) and increases access to amino-acid residues previ-
ously buried or shielded from the solvent. Addition of the thiol-
reactive coumarin, CPM,will provide rapid covalent labelling of exposed
cysteine residues. Upon covalent attachment, CPM displays increasedﬂuorescence and the rate of incorporation into the proteins was used
to reﬂect structural destabilisation.
A typical CPM labelling proﬁle for ABCA4 is shown in Fig. 5a over a
2 hour incubation period at 40 °C. The ﬂuorescence increased in a
hyperbolic manner and was transformed into a stability curve as seen
in Fig. 5b. The stability at the start of the incubation periodwas assigned
a value of 1.0 and a half-life for the decay associated with denaturation
was generated from this plot. ABCA4, puriﬁed in FC-16 containing buffer
was characterised by a denaturation half-life of 15.4 ± 5.7 min and
several additives and buffer conditions were examined for their ability
to alter this value. A selection of the additives investigated is shown in
Fig. 5c. The crude lipid mixture asolectin signiﬁcantly increased the
half-life to 44.8 ± 2.0 min (P b 0.05), indicating an improved stability
of the protein. Similarly, a mixture of E. coli crude lipid extract and
cholesterol (4:1 w/w) also increased the stability of ABCA4 with a 2.9-
Fig. 5.Using the thermal stability assay to assess the effects of additives on protein stability. Concentrated, puriﬁed protein was diluted into a range of puriﬁcation buffers and its thermal sta-
bility at 40 °C was measured using a coumarin–maleimide (CPM) binding assay. Each puriﬁcation buffer was based on a composition of 20 mMMOPS pH 7.4, 200 mM NaCl and 10% (v/v)
glycerol. For ABCA4 the buffer included 0.01% (w/v) FC-16 and for ABCB1 the detergent was 0.05% (w/v) DDM. a) The panel shows the increase in ﬂuorescence during a typical incubation of
ABCA4with CPMunder standard conditions over a 150 minute period. The dashed line represents themaximalﬂuorescence intensity. b) The ﬂuorescence data of panel a)was normalised by
expressing as a fraction of themaximal ﬂuorescence intensity. The dashed line demonstrates the interpolation to generate a half-life for the covalent attachment of CPM to ABCA4. c) The half-
life for labelling of ABCA4 in the presence of a series of additives. The additives include: PC (addition of 0.1% phosphatidyl choline); aso (addition of 0.1% soy bean asolectin); E. coli/cholesterol
(addition of 0.16% (w/v) E. coli lipids and 0.04% (w/v) cholesterol); DDM, OG, FC16, FC14 (omission of 0.01% (w/v) FC-16, inclusion of dodecylmaltoside, octylglucoside, fos-choline 16 or fos-
choline 14 at 3-times their critical micelle concentration); and 2% gly (substitution of 10% (v/v) glycerol for 2% (v/v) glycerol). The protein in its standard buffer is shown and the horizontal
dashed line provides another representation of this value for comparison with the other buffer conditions. d) The half-life for labelling of ABCB1 in the presence of a series of additives. The
additives include: aso (addition of 0.1% (w/v) soy bean asolectin); CHS (addition of 0.01% (w/v) cholesterol hemi-succinate); DDM, DM, NM, OG (omission of 0.05% (w/v) dodecyl-β-D-
maltoside, and inclusion of dodecyl-β-D-maltoside, decyl-β-D-maltoside, nonyl-β-D-maltoside or octylglucoside, at 3-times their critical micelle concentration); and no gly (omission of
10% (v/v) glycerol). The protein in its standard buffer is shown and the horizontal dashed line provides another representation of this value for comparison with the other buffer conditions.
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of pure phosphatidyl-choline did not alter the stability of ABCA4.
ABCA4 was puriﬁed in FC-16 and increasing the detergent concen-
tration from 0.01 to 0.03% (w/v) produced a 2.6-fold increase in the
half-life; whereas the inclusion of the shorter alkyl-chain (and higher
CMC) FC-14 did not alter the stability. The alkyl-maltoside (DDM) and
alkyl-glucoside (OG) detergents also conferred increased stability to
the puriﬁed protein with elevations in the half-life to 25.8 and
27.6 min respectively. These results indicated that despite the difﬁculty
in solubilising the protein from insect cell membranes, puriﬁed ABCA4
was thermally stable in a range of detergents.
Finally, reduction of the concentration of osmo-protectant glycerol
in the buffer from 10% (v/v) to 2% (v/v) did not signiﬁcantly alter the
stability of ABCA4. This suggested that ABCA4 could tolerate a reduced
glycerol concentration,which is of considerable beneﬁt in crystallisation
procedures.
The denaturation of ABCB1 at 40 °C in the DDM containing puriﬁca-
tion bufferwas characterised by a half-life of 32 ± 11 min. The addition
of related detergent species, with variable alkyl chain lengths, did not
signiﬁcantly alter the denaturation half-life of ABCB1 (Fig. 5d). The pu-
riﬁed protein also had acceptable thermal stability in bufferwith glycer-
ol at b10% (v/v) and even in the absence of osmo-protectant the half-life
was only reduced to 19 ± 2 min. This condition is essential for analyt-
ical methods which require low viscosity such as SAXS, SANS, and static
light scattering.
The only additive to signiﬁcantly increase themean thermal stability
of ABCB1 was 0.01% (w/v) cholesteryl hemisuccinate (CHS). Theaddition of CHS increased the denaturation half-life from 32 ± 11 min
to 58 ± 13 min and indicates stabilisation of the protein in the pres-
ence of exogenous cholesterol derivative.
3.8. Does increased stability afforded by lipid derivatives equate to im-
proved homogeneity?
The inclusion of crude lipid mixtures or CHS was shown to improve
the structural stability of ABCA4 and ABCB1 respectively. GPC was used
to ascertain whether the lipid based additives produced further im-
provement in the homogeneity of the puriﬁed proteins. Both proteins
were puriﬁed as described previously with the lipid additives included
from the solubilisation step and retained throughout the procedure.
Fig. 6a demonstrates the GPC proﬁle obtained for ABCA4 puriﬁed in
0.01% FC-16 in the presence or absence of 0.1% (w/v) asolectin. In the
absence of added lipid, the ABCA4 protein proﬁle was characterised by
a large and nearly symmetrical peak at a RV = 11 ml. However, the
inclusion of asolectin during puriﬁcation produced a rather complex
GPC proﬁle. A signiﬁcant amount of the protein was located within
the void volumewith a RV = 8 ml, which is suggestive of increased ag-
gregation. In addition, therewas nomajor peak at RV = 11 ml although
a large peakwas found at RV = 9.2 ml. Finally, a peak corresponding to
lower molecular weight at a RV = 15 ml was also observed. Although
the structural stability of ABCA4 was improved by the inclusion of
crude lipids, the GPC analysis suggested that the protein was found in
multiple conﬁgurations. The states presumably reﬂect aggregation of
the protein and/or a signiﬁcantly modiﬁed detergent–lipid micelle
Fig. 6. Effects of exogenous lipids on the homogeneity of ABCB1 and ABCA4. Typical GPC
traces are shown for (a) ABCA4 and (b) ABCB1 obtained in the absence (solid lines) and
presence (dashed lines) of exogenous lipids. Imidazole used in eluting protein from Ni-
NTA resin and was removed using PD-10 columns. The exogenous lipid used in ABCA4
puriﬁcation was 0.1% (w/v) asolectin. The exogenous lipid used in the puriﬁcation of
ABCB1 was 0.01% (w/v) CHS. Proteins were identiﬁed by absorbance at 280 nm using
the chromatography system ﬂow cell. Spectral intensities for each trace were normalised
with the assignment of the main peak intensity for ABCA4/ABCB1 to 100. ABCA4 and
ABCB1 were resolved on Superose 6 and Superdex 200 columns respectively.
Fig. 7. Effects of CHS on ATP hydrolysis by ABCB1. The ATPase activity of ABCB1 wasmea-
sured at the following stages of puriﬁcation: (i) post-metal afﬁnity chromatography,
(ii) after removal of imidazole using a PD-10 column, (iii) after centrifugal concentration
and (iv) following gel permeation chromatography. The ATPase activity was measured
from 200 ng puriﬁed ABCB1 incubated at 37 °C for 20 min. The hydrolysis of ATP was
detected by the liberation of free phosphate using a colorimetric assay as described in
the Materials and methods section. Stimulated activity was measured in the presence of
10 μM nicardipine. Activities were measured for protein in the absence (dotted bar,
basal; angled stripes, stimulated) or presence (□ basal; ■ stimulated) of 0.01% (w/v)
CHS. The dashed lines represent the ATPase activity of ABCB1 in the absence (lower) or
presence (upper) of nicardipine.
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the zwitterionic FC-16 to the non-ionic DDM also produced a complex
GPC proﬁle with multiple peaks at a range of retention volumes (data
not shown). One interpretation is that ABCA4 adopts a number of con-
ﬁgurations when isolated from biological membranes and the simple
single detergent system without lipids is more likely to promote
mono-dispersity.
Fig. 6b provides theGPC proﬁle for ABCB1 puriﬁed in the presence or
absence of 0.01% (w/v) CHS using the detergent DDM (0.05% w/v). As
described in a previous section, the main peak for ABCB1 (RV =
11.5 ml) contained a small shoulder peak from the void volume that
caused an asymmetric appearance. Inclusion of CHS greatly improved
the GPC proﬁle by reducing the proportion of protein contained within
the void volume and thereby rendering the peakmore symmetric. Thus,
the combination of removing imidazole and the inclusion of CHS
produced signiﬁcant improvements in the homogeneity of puriﬁed
ABCB1; in particular, this strategy reduced the amount of protein
appearing in a high molecular weight aggregated state.3.9. Does increased structural stability afforded by lipid derivatives equate
to improved activity of ABCB1?
The inclusion of CHS resulted in increased structural stability and
greater homogeneity for ABCB1 following puriﬁcation. The procedure
involved four discrete stages: (a)metal afﬁnity chromatography, (b) re-
moval of imidazole using PD-10 columns, (c) centrifugal concentration,
and (d)GPC. TheATPase activity of ABCB1wasmeasured following each
of these treatments to assess their effects on activity and the ability of
CHS to prevent any perturbation.
The activity of ABCB1 following metal afﬁnity chromatography in
the absence of CHS was characterised with a basal VMAX = 3.3 ±
1.6 nmol/min/mg and this was stimulated 3-fold by nicardipine
(10 μM) to VMAX = 9.9 ± 2.9 nmol/min/mg. Progression of the sample
through subsequent stages of puriﬁcation did not see any alteration in
this low level of basal or stimulated activity (Fig. 7).
In the presence of CHS, the basal ATPase activity was raised to
VMAX = 14 ± 5 nmol/min/mg and the stimulated activity was in-
creased 11-fold to VMAX = 110 ± 46 nmol/min/mg (Fig. 7). Removal of
imidazole did not have a signiﬁcant impact on the basal (VMAX = 21 ±
5 nmol/min/mg) or nicardipine stimulated (VMAX = 97 ± 32 nmol/
min/mg) ATPase activity. However, the centrifugal concentration step
was associated with a drop in the drug stimulated activity to VMAX =
43 ± 18 nmol/min/mg indicating some inactivation of the protein. Not-
withstanding this, the data in this investigation reveals a key role for a
cholesterol derivative in maintaining stability and homogeneity of the
protein following extraction from the lipid bilayer.
TheATPase activitieswere determined usingABCB1 in detergentmi-
celle suspensions since this is the form used in structural andmany bio-
physical applications. We have previously demonstrated that human
[19,36] and hamster [37] isoforms of ABCB1 display considerable in-
crease in ATPase activity following reconstitution into speciﬁc bilayer
environments.
3.10. Does increased structural stability afforded by lipid derivatives equate
to improved activity of ABCA4?
Crude lipidmixtures were also shown (Fig. 5c) to increase the struc-
tural stability, though not themono-dispersity, of ABCA4. Consequently,
the ability of a variety of lipid species to support the ATPase activity of
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protein (i.e. immediately post-metal afﬁnity chromatography) using a
sensitive [32P]-ATP based assay. Puriﬁcation of ABCA4 in the absence
of any lipid additive caused a complete inactivation of the ATPase activ-
ity of the protein, although in all cases saturable and displaceable [γ32P]-
8N3-ATP binding was still observed (data not shown). This is presum-
ably due to the effects of FC-16 on the protein directly, or through
delipidation during the chromatographic steps. The inclusion of
asolectin, pure phosphatidyl-choline or a mixture of E. coli crude lipid
extract and cholesterol (4:1 w/w) failed to provide any protection
from this inactivation. This is in contrast to the ability of the two crude
lipid mixtures to improve the structural stability of ABCA4.
ABCA4 is located within disc membranes of photoreceptor cells and
these specialised organelles contain distinct lipid proﬁles. In particular,
the discs have increased proportions of phosphatidyl-ethanolamine,
an abundance of long chain polyunsaturated constituent fatty acids
and, as they migrate towards the disc tip, lower amounts of cholesterol.
To provide an approximation of this lipid environment, ABCA4 was
puriﬁed in the presence of brain PE exclusively or with a crude brain
extract.
In the presence of crude brain lipid extracts, the maximal activity
in the absence of substrate (i.e. basal) was determined as VMAX =
128 ± 16 nmol/min/mg, with an afﬁnity constant of KM (ATP) =
2.7 ± 0.5 mM (Table 1). The inclusion of brain PE also supported
ATPase activity (VMAX = 138 ± 12 nmol/min/mg) that was indis-
tinguishable from the crude brain lipid mixture.
Retinol and retinal did not lead to signiﬁcant stimulation of ATPase
activity of ABCA4 in any of the lipid mixtures. Previous reports of stim-
ulation of ATPhydrolysis by these compounds resulted in only relatively
minor increases in the basal activity (~1.25 fold). As shown in Table 1,
beryllium ﬂuoride and the non-hydrolysable ATP analogue AMP-PNP
were able to inhibit the basal rate of ATP hydrolysis.
Inclusion of cholesterol has been demonstrated to improve rates of
ATP hydrolysis for a number of ABC proteins and was added to the
crude brain mixture in a ratio of 1:4 (w/w). However, this supplemen-
tation caused a statistically signiﬁcant (P b 0.05) 60% reduction in the
basal ATPase activity to VMAX = 53 ± 6 nmol/min/mg. Intriguingly,
the other major protein component of disc membranes, rhodopsin, is
also inhibited by cholesterol.
Clearly, the structural integrity ABCA4 and its function are heavily
reliant on the presence of a speciﬁc lipid environment. Unfortunately,
the GPC proﬁles indicate that the inclusion of lipids lead to greater het-
erogeneity in the sample. In order to resolve this apparent dichotomy
we used electron microscopy to examine the nature of puriﬁed ABCA4
(Section 3.11).Table 1
Activity of ABCA4 at each stage of puriﬁcation; effects of lipids. ABCA4 was puriﬁed in the
presence of three distinct lipid mixtures; (i) brain PE, (ii) a crude brain lipid mixture or
(iii) crude brain lipid mixture in the presence of 20% (mol/mol) of cholesterol. ATPase
activity was characterised at distinct ATP concentrations to generate parameters of maxi-
mal activity (VMAX) and afﬁnity for substrate (KM) through non-linear least squares regres-
sion of the Michaelis–Menten equation. ABCA4 puriﬁed in a crude brain lipid mixture was
also examined at a ﬁxed ATP concentration (2 mM) in the presence of varying concentra-
tions of berylliumﬂuoride or AMP-PNP. The extent of ATPase activity remaining (EXT) and
the potency to inhibit hydrolysis (IC50) were obtained using non-linear regression of
the general dose–response relationship. Values correspond to mean ± SEM and were
obtained from at least four independent observations.
Brain PE Crude brain Crude brain + cholesterol
Activity
VMAX (nmol/min/mg) 138 ± 12 128 ± 16 53 ± 6
KM (mM) 4.5 ± 0.9 2.7 ± 0.5 1.7 ± 0.2
Bex·F inhibition
Extent 0.55 ± 0.03
IC50 (mM) 0.83 ± 0.17
AMP-PNP inhibition
Extent 0.55 ± 0.03
IC50 (mM) 0.83 ± 0.173.11. Electron microscopy based structural studies of ABCA4
Transmission electron microscopy (TEM) is a powerful diagnostic
tool in assessing the potential suitability of a protein preparation for
2D and 3D crystallisation trials for several reasons. Firstly, an initial ben-
eﬁt of screening using TEM is that small scale trial preparations and low
protein concentrations can be readily accommodated — a typical nega-
tive staining TEM experiment may require 10 μl of sample at a concen-
tration of 25–50 μg/ml, whilst a 3D crystallographic screen may use a
similar volume but requires a protein concentration perhaps 200×
higher. Secondly, electron microscopy (EM) can provide data on “struc-
tural purity”, a term thatwe use to encompass sample homogeneity and
mono-dispersity, aggregation state, and the stability of a speciﬁc
conformation.
Finally, routine screening of repeat samples by TEM allows assess-
ment of problems that may arise from batch-to-batch variability. The
negatively stained ABCA4 sample (Fig. 8a) clearly showed that the
ABCA4 protein was present as a mono-disperse population of particles
measuring ~110–150 Å. Therewas no signiﬁcant detergent background
or particle aggregation, although particles were closely packed on the
carbon support ﬁlm. The particles also ranged in shape from globular/
oval to sandwich like double-layered indicating that the protein had
naturally adhered to the support grid in a variety of views. Previous
TEM studies on detergent solubilised ABC proteins have reported a vari-
ety of oligomeric forms and sizes.With these previous data inmind, and
given that the ABCA4 topology prediction [27] indicated signiﬁcant
extra mass beyond the TMDs, our initial expectation was to expect a
particle that was perhaps oligomeric and up to ~200 Å in the longest
dimension.
EMAN2 was used to select 5300 well separated particles (Fig. 8b)
and following iterative-MSA class averaging [34], produced crisp projec-
tion averages with a clearmatch to the raw data. These projectionmaps
(Fig. 8c) corresponded to different projection averages of the protein,
with some classes presenting a skewed toroidal projection and others
a much more sandwich-like particle with a pseudo-mirror symmetry
axis.
3.12. Interpretation of the 3-D structure of ABCA4
The ﬁnal 3-D volume of the ABCA4 complex had dimensions of
140 × 150 × 110 Å3, and is a consistent volume to ﬁt a dimer of
ABCA4 molecules (2 × 240 kDa) along with their associated detergent
micelles (~70 kDa [38]; Fig. 8d). Using the high-resolution structure of
Sav1866 (low pass ﬁltered to 20 Å) as an approximation of the TMD
and NBD regions of the ABCA4 protein, regions of density with a high
correlation (0.91 at 26 Å resolution) can be identiﬁed and only have
one consistent orientation. Viewed from the side in surface render
(Fig. 8d), the dimeric complex has a rounded pentagonal star appear-
ance, with the putative NBDs and TMD domains forming the outside
corners of the star. There is considerable additional density located at
the apex of the complex and at the interface of the twomonomeric pro-
teins the electron density for these portions of the map overlaps, was
much less well-deﬁned at lower σ values and more variable than the
other map densities. To clarify the interpretation of the structure, we
segmented the 3-D volume into each half of the dimeric complex,
shown in the lower panels of Fig. 8d. By removing the front monomer,
we are able to assign three structural “lobes” to the rendered surface.
These have been putatively assigned these as the TMD (blue), NBD
(green) and extracellular domains (ECD) (magenta) regions of ABCA4
(Fig. 8d, bottom panel). The ECDs of ABCA4 are predicted to form two
soluble domains of 60 kDa and 30 kDa respectively, which are oriented
towards the lumen of the outer segment discs. It has been suggested
that disulphide bridges connect the two ECDs in ABCA proteins, and
these bridges are essential for their function [27,39]. Since the ECDs
are believed to be crosslinked [11], it is reasonable to assume that the
density for these regions in the EM map would be contiguous; based
Fig. 8. 3-D Structural analysis of ABCA4 by electron microscopy and single particle analysis. CCD images of negatively-stained detergent solubilised ABCA4 (a) were recorded and showed
clear oligomeric protein particles of ~13–16 nm— Scale bar = 100Ǻ. Individual particles were selected from these micrographs into 64 pixel2 boxes (b) and sorted into different orien-
tation classes using iterative MSA (c). 3D reconstruction using EMAN2 produced a 26 Ǻ resolution electron density map of the protein (two side views shown in d). Themap consisted of
two groups of three domains (coloured in green, blue and magenta), consistent with a dimer of ABCA4, each half consisting of a transmembrane domain (TMD), two nucleotide binding
domains (NBDs) and two extra-cytoplasmic domains (ECDs). One half of the map is shown with the high resolution structure of Sav1866 (yellow) ﬁtted into the TMD/NBD region using
Chimera.
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remaining density, approximately one third of the total volume and a
total of 4.36 × 105 Ǻ3, must contain the ECDs. It is interesting to note,
that these regions did not project directly out beyond the TMD region
and appeared to loop around and form extensive contacts with the hy-
drophobic TMD region.
During preparation of this manuscript a publication from Tybovsky
et al. generated an electron microscopy based structure for ABCA4[40]. The data was produced using some different methodology and
highlighted some obvious structural differences to the data produced
here. Tsybovsky et al. puriﬁed ABCA4 fromBovine outer rodmembranes
using DDM as their detergent of choice and subsequently used the ran-
dom conical tilt method on a dataset of ~25 K of particles; the resulting
3-D structure from sharp projection averages was at a reported resolu-
tion of 18 Å. Firstly, the data produced by Tsybovsky et al. clearly shows
a monomeric organisation of ABCA4 in contrast to the dimer produced
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oligomerisation [41] and of membrane proteins existing in multiple
promiscuous oligomers [42]. In this case it is difﬁcult to unambiguously
state which has the ‘more correct’ in vivo relevance, unless a structure is
calculated from the lipid bilayer directly. Comparing the two monomer
structures, the overall size and distribution of domains is very similar,
although in the data we produce the ECDs within the dimer are folded
inwards towards the dimer interface. Whilst we believe this packing
organisation is likely to have no physiological signiﬁcance, it is interest-
ing to note the monomeric structure of ABCA4 is much more rigid in
comparison. Clearly in the case of ABCA4, the choice of detergent affects
not only the puriﬁed oligomeric state, but also theﬂexibility and confor-
mation of the protein produced.
4. Discussion
Our ongoing research focus is to reveal the molecular mechanisms
underlying trans-membrane translocation by eukaryotic ABC proteins.
The strategy combines biochemical, biophysical and structural studies
of puriﬁed transporters, which necessitates the production of puriﬁed
transporters at a high yield.
Sufﬁcient expression of ABCB1 and ABCA4 has been achieved
through the infection of insect cells using recombinant baculovirus.
Poly-histidine tags engineered into both proteins enabled their rapid
puriﬁcation by IMAC. GPC, an iso-thermal stability assay, and (for
ABCA4) EM techniques have been used to iteratively reﬁne the puriﬁca-
tion procedures, improve the yield and optimise the sample homogene-
ity. The most signiﬁcant improvements have resulted from optimising
buffer components throughout the process. These improvements in
protein homogeneity also contributed to improvements in the ATPase
activity of both transporters in a detergent micelle matrix. Finally, the
use of EM has also generated structural data for ABCA4.
Embarking on structural or biophysical studies with membrane
proteins requires judicious choice of expression system. Although ex-
pression in E. coli is a popular ﬁrst choice for many investigators there
can be serious issues with folding, stability, and assembly of largemem-
brane proteins [43–45]. Insect cells were chosen ahead of yeast expres-
sion due to prior laboratory experience, their ability to mediate core
glycosylation [46–48] and provide a phospholipid environment more
similar to mammalian cells [49] though the membrane sterols in both
yeast and insect cells differ from those in mammalian cells [45].
Extraction of proteins from the source membranes is a frequent
“bottleneck” in the isolation of membrane transporters [44,50]. The
general physical properties of detergents including their alkyl chain
length, CMC, and the size or charge of the polar head group, can indicate
their ability to solubilise membrane proteins. However, it remains
impossible to accurately predict the ability of each detergent to solubi-
lise a speciﬁc protein. For instance, previous studies have demonstrated
that ABCB1 is readily extracted from insect and mammalian cell mem-
branes using a variety of detergent classes [15,51–53]. By contrast,
ABCA4 was difﬁcult to extract from Sf9 insect cell membranes; only
the long-chain zwitterionic fos-cholines were able to solubilise the pro-
tein. This observation was reiterated in our laboratory for ABCG2 [27]
and there are numerous other examples where the fos-cholines provid-
ed improved extraction of membrane proteins [5,54–56]; however
there are scant reports of their effects on protein activity.
Another ABC transporter, the prokaryotic BmrC/D transporter also
proved difﬁcult to extract from membranes and repeatedly formed
higher order aggregates followingpuriﬁcation [57]. Here again, shorten-
ing the time for protein production (i.e. post-infection of insect cells
with baculovirus) lowered the overall ﬁnal yield but signiﬁcantly
reduced the degree of BmrC/D aggregation. Our experience indicates
that increasing the period of baculovirus infection provided consider-
ably greater yield for ABCB1 and ABCA4, but at a cost of reduced
“extractability”. This fraction of “late-stage” insoluble protein may re-
ﬂect an increased amount of mis-folded protein, or may reﬂectmembrane protein aggregation within the membrane itself resulting
in limiting exposure to detergents during solubilisation [43,44,58,59].
Such a scenario may limit extraction of the protein or lead to extraction
of proteins in an oligomeric conﬁguration.
It is clear that the optimal detergent for extraction may not be suit-
able for down-stream applications such as functional assessment or
crystallisation [5,44]. For instance detergents with low CMCs may be
difﬁcult to remove during reconstitution, and long alkyl chains may be
more disruptive to crystal contacts. As indicated from our investigations
with several ABC transporters, even related proteins may have distinct
extraction proﬁles. In addition, the speciﬁc cellular membrane environ-
ment will also inﬂuence extraction. However, the extracting detergent
may be substituted for one that supports downstream analysis during
chromatographic puriﬁcation [55].
Successful structural determination of membrane proteins requires
protein samples that are not only pure but also monodisperse. Using
GPC, we identiﬁed high molecular weight species migrating in the
void volume of theGPC columns,which indicated the presence of aggre-
gated species. These ABC transporters may form aggregates within the
insect cells during the protein production phase following infection
with recombinant baculovirus. Alternatively the appearance of ABCB1
or ABCA4 aggregates following puriﬁcation may result directly from
the process of extraction by detergent.
Buffer composition is an oft-ignored, or relegated to “bystander”,
inﬂuence on the stability and integrity of puriﬁed proteins. Yet as sever-
al authors have shown, the inﬂuence of pH, glycerol content and ionic
strength on the aggregation state of a number of membrane proteins
[29,30,60], including ABCB1 [61], vary from case to case. Here, we
observed that the cholesterol derivative (cholesteryl hemi-succinate)
was shown to provide considerable stability to detergent soluble
ABCB1 against thermal denaturation and reduced the high molecular
weight shoulder peak in the gel permeation chromatography spectrum.
This suggests that the cholesterol derivative may prevent the formation
of ABCB1 aggregates in the mixed micelle suspensions. The inclusion of
CHS allowed drug stimulated ATPase activity to be retained by ABCB1 in
thedetergent solubilised state, in contrast to previous observationswith
detergent soluble ABCB1 [15,36,62]. The “protective” effect of CHS
agrees with an earlier investigation using reconstituted ABCB1 [61].
We suggest that this effect is due to CHS conferring a reduction in ﬂuid-
ity to the micelle in the same way that cholesterol and sphingolipid-
mediated ordering of the membrane is conducive to optimal activity
of reconstituted ABCB1 [21,36].
Our analysis of buffer components also revealed that these can inﬂu-
ence the aggregation and precipitation of protein during puriﬁcation
and concentration. As previously described, centrifugal concentrators
can result in aggregation or precipitation of membrane proteins [58].
We observed that this was compounded by the presence of eluting
concentrations of imidazole, as revealed by theGPC proﬁles. The remov-
al of imidazole both improved the GPC proﬁle, and reduced the extent of
protein precipitation during centrifugal concentration, yielding protein
samples in the range 10–15 mg/ml. However, in the case of ABCA4,
for the protein to reach a high concentration without aggregation, it
also required the right detergent.
The isothermal denaturation assay identiﬁed lipid additives that im-
proved the stability of ABCA4 solubilised by fos-choline detergents and
the highest stability was afforded by the crude lipid mixtures asolectin
and E. coli lipids. Asolectin comprises approximately equal proportions
of PC, PE and PI with a distribution of alkyl chain lengths and degrees
of saturation. The E. coli lipid extract comprises 58% PE, 15% PG and
10% cardiolipin, also with a range of alkyl chain properties. In contrast
the use of egg-PC, which contains a single lipid head group, was not
able to improve ABCA4 stability. The crudemixtures are unlikely to pro-
vide an ordered lipid environment per se, but their inclusion is likely to
render the mixed micelles more rigid than detergent alone [63–66].
The two crude lipid mixtures that provided thermal stability to
ABCA4 contain relatively high amounts of PE. A wide range of lipid
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ﬁed ABCA4 and optimal function was obtained in brain PE and crude
brain lipids (33% PE, 12% C, and 19% PS). Clearly, a high proportion of
PE is a key lipid in the functional and structural integrity of ABCA4. In
addition, these two lipid mixtures also contain a high proportion of
long and highly unsaturated alkyl chains (Brain PE: 24% 18:1, 12%
22:6, and 19% 20:4). PE has a small head group in relation to other nat-
ural lipids and is unable to form conventional bilayers on its own. Thus,
the combination of PE and highly unsaturated lipids precludes the for-
mation of highly ordered lipid domains. However, ABCA4 in pure mi-
celles of fos-choline, and therefore disordered, is void of functional
activity. This would suggest that a direct interaction between PE-
based lipid species and ABCA4 is crucial to the protein's integrity.
The advent of heterologous expression systems and afﬁnity tags
has facilitated the production of highly puriﬁed and stable membrane
proteins; a task that has long been viewed as very challenging. Our
experience in these systems has led us to establish the following recom-
mendations for any novel membrane protein puriﬁcation protocol.
Firstly, in order to produce both functional and structurally pure sam-
ples, a critical assessment of the protein stability or homogeneity should
be undertaken prior to functional or structural investigations, since each
additional stage of the laborious puriﬁcation procedure has the ability to
reduce both protein quality and quantity. Relating to this, wewould ini-
tially suggest a series of empirical observations on the effects of deter-
gents, lipids and buffer components on the puriﬁcation, since these
factors can have a large effect on protein stability but are relatively eas-
ily reﬁned. Moreover, a range of assays to examine the protein stability,
such as GPC and thermal stability assays should then be employed since
they will generate distinct datasets. Finally, the functional activity of
membrane transporters will correlate strongly with the integrity of
the puriﬁed product, a vital consideration for undertaking structural
studies. That said, in this case, we have an interesting caveat since fol-
lowing removal from themembrane bilayer the single particle structure
of ABCA4 has revealed an unusual quaternary organisation. Here, we
would suggest that during puriﬁcation the ECDs of the protein have
packed stably into the side of the complex and for this to have occurred,
the ECDs would have to represent a highly mobile hinged domain or a
naturally disordered region of the protein in vivo. These structural
data suggest that despite its high purity, stable nature and mono-
dispersity, ABCA4 puriﬁed in this way may represent a non-ideal con-
formation to pursue a 3-D crystallisation route. Screening further condi-
tions to stabilise the ECDs (e.g. crosslinking using the GRAFIX method
[67] or co-puriﬁcation with ligand bound) would perhaps yield a prep-
aration that more reﬂects the physiological organisation and optimised
for 3-D crystallisation.
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